Perceptive Advisors - 4D MOLECULAR THERAPEUTICS IN ownership

4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 78 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of 4D MOLECULAR THERAPEUTICS IN
ValueSharesWeighting
Q3 2021$10,121,000
-44.0%
375,256
-50.0%
0.15%
+25.6%
Q2 2021$18,072,000
-6.4%
750,512
+68.7%
0.12%
-52.0%
Q1 2021$19,298,000
-22.4%
444,878
-25.9%
0.24%
-8.6%
Q4 2020$24,881,000600,2560.27%
Other shareholders
4D MOLECULAR THERAPEUTICS IN shareholders Q4 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 3,000,000$38,190,0004.02%
Casdin Capital, LLC 1,033,811$13,160,4141.46%
BVF INC/IL 4,007,413$51,014,3671.38%
Deep Track Capital, LP 2,778,107$35,365,3021.36%
Opaleye Management Inc. 308,500$3,927,2051.28%
Eagle Health Investments LP 437,911$5,574,6071.23%
Novo Holdings A/S 1,200,000$15,276,0001.13%
RA Capital Management 4,163,211$52,997,6761.04%
VIKING GLOBAL INVESTORS LP 4,787,914$60,950,1450.25%
HighVista Strategies LLC 33,419$425,4240.20%
View complete list of 4D MOLECULAR THERAPEUTICS IN shareholders